Cupid Q2 profit jumps 133%, raises FY27 revenue guidance to ₹880 crore

ملخص مفصل

The company reported a 132% year-on-year rise in Q2 FY27 total income to ₹208.97 crore and a 133% increase in net profit to ₹56.22 crore. It expects H2 to be significantly…

Cupid Ltd. has raised its FY27 revenue guidance to at least ₹880 crore and net profit guidance to ₹275 crore or more, following a strong performance in the first half of the financial year.

The company reported total income of ₹208.97 crore in Q2 FY27, registering a 132% year-on-year increase and a 33% rise sequentially. Operating income stood at ₹187.86 crore, up 122% from the corresponding quarter last year.

Net profit for the quarter increased 133% year-on-year to ₹56.22 crore, while Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) stood at ₹54.77 crore, with a margin of 29%.

For the first half of FY27, total income rose 136% year-on-year to ₹365.95 crore, while net profit increased 156% to ₹100.37 crore. EBITDA also grew 156% to ₹114.83 crore.

The domestic business contributed ₹224.64 crore, accounting for 67% of H1 FY27 sales, compared with 41% in FY26. The Consumer Healthcare and FMCG business contributed ₹166.88 crore, representing 49% of sales.

The international business contributed ₹112.73 crore, or 33% of H1 sales, supported by institutional demand through the PFSCM agreement and supplies under South Africa's 2025–30 national programme. The company said price revisions across its export portfolio were reflected in realisations for the full first half.

Cupid expects its Palava manufacturing facility in Maharashtra to be commissioned in Q3 FY27. The approximately 1,70,000-square-foot facility is expected to take the company's annual manufacturing capacity to around 1.25 billion male condoms and 125 million female condoms, from the current 480 million and 52 million, respectively, at Sinnar.

The facility will have dual-polymer dipping lines, enabling production in natural rubber latex and nitrile. This is expected to support the development of nitrile female condoms and the company's participation in additional global nitrile tenders.

The company expects the facility's commissioning to support higher volumes in the second half of FY27 across…

مطلع المقال، مقتطف من CNBC-TV18. لقراءة المقال كاملًا، افتحه على موقع الناشر.